[Treatment of pyknoleptic petit mal epilepsy and juvenile myoclonic epilepsy with dipropyl acetate (Deprakine). A pilot study of therapy-resistant patients during control of plasma concentration].
D000293:Adolescent; D000328:Adult; D002648:Child; D002986:Clinical Trials as Topic; D004341:Drug Evaluation; D004351:Drug Resistance; D004831:Epilepsies, Myoclonic / Q000188:drug therapy*; D004832:Epilepsy, Absence / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008297:Male; D010865:Pilot Projects; D014631:Valerates / Q000627:therapeutic use*; D014635:Valproic Acid / Q000008:administration & dosage / Q000097:blood / Q000627:therapeutic use*
D014631:Valerates; D014635:Valproic Acid